Results

201.

Bousquet, J.⁺, Samolinski, B., Kaidashev, I., Maurer, M., Roche, N., Sousa-Pinto, B., Kurchenko, A., Stepanenko, R., Tsaryk, V., Klimek, L., Ventura, M. T., Bedbrook, A., Czarlewski, W., Lysanets, Y., Kupczyk, M., Skolimowski, Ł., Kulus, M., Del Giacco, S., Ollert, M., Garcia-Aymerich, J., Robalo Cordeiro, C., Yorgancioglu, A., Schlapbach, C., Amaral, R., Bonaglia, C., Bossé, I., Buquicchio, R., Christou, D., Fedoruk, G., Fontanesi, P., Gemicioglu, B., Giuliano, A. F. M., Lepore, P., Nakonechna, A., Neisinger, S., Pereira, A. M., Ramanauskaite, A., Raciborski, F., Sitkauskiene, B., Sokhatska, O., Stepanenko, V., Stevanovic, K., Syzon, O., Kvedariene, V., de Vries, G., van Eerd, M., Valiulis, A., Fonseca, J. A., Anto, J. M., Haahtela, T., Schünemann, H., and Zuberbier, T.: UCRAID (Ukrainian Citizen and refugee electronic support in Respiratory diseases, Allergy, Immunology and Dermatology) action plan. Allergy 2023: 78; 2581-2595. IF: 12.60

202.

Neisinger, S.⁺, Ramanauskaite, A., Kocatürk, E., Britz, R., Lingnau, A., Cherrez-Ojeda, I., and Maurer, M.: Embracing digital health solutions: the pivotal role of the CRUSE app in chronic spontaneous urticaria management. Asthma Allergy Immunol. 2023: 21; 79-81. IF: 0.3

203.

Kolkhir, P.⁺, Akdis, C., Akdis, M., Bachert, C., Bieber, T., Canonica, G., Guttman-Yassky, E., Metz, M., Mullol, J., Palomares, O., Renz, H., Ständer, S., Zuberbier, T., and Maurer, M.⁺: Type 2 chronic inflammatory diseases: targets, therapies and unmet needs. Nat. Rev. Drug Discov. 2023: 22; 743-767. IF: 122.70

204.

Asero, R.^+*, Ferrer, M.^*, Kocatürk, E.^*, and Maurer, M.^*: Chronic spontaneous urticaria: the role and relevance of autoreactivity, autoimmunity and autoallergy. J. Allergy Clin. Immunol. Pract. 2023: 11; 2302-2308. IF: 8.20

205.

Charles, N.⁺, Kortekaas Krohn, I., Kocatürk, E., Scheffel, J., Altrichter, S., Steinert, C., Xiang, Y.-K., Gutermuth, J., Reber, L., and Maurer, M.^*: Autoreactive IgE: pathogenic role and therapeutic target in autoimmune diseases. Allergy 2023: 78; 3118-3135. IF: 12.60

206.

Casale, T. B.⁺, Giménez-Arnau, A. M., Bernstein, J. A., Holden, M., Zuberbier, T., and Maurer, M.: Omalizumab for patients with chronic spontaneous urticaria: a narrative review of current status. Dermatol. Ther. 2023: 13; 2573-2588. IF: 3.50